These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26285449)

  • 1. [GENERAL AND PERSONALIZED APPROACH OF BIOMARKERS].
    Cavalier E
    Rev Med Liege; 2015; 70(5-6):257-61. PubMed ID: 26285449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future: biomarkers, biosensors, neuroinformatics, and e-neuropsychiatry.
    Lowe CR
    Int Rev Neurobiol; 2011; 101():375-400. PubMed ID: 22050860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering influence links in molecular knowledge networks to streamline personalized medicine.
    Shin D; Arthur G; Popescu M; Korkin D; Shyu CR
    J Biomed Inform; 2014 Dec; 52():394-405. PubMed ID: 25150201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
    Ahmed MU; Saaem I; Wu PC; Brown AS
    Crit Rev Biotechnol; 2014 Jun; 34(2):180-96. PubMed ID: 23607309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel droplet platforms for the detection of disease biomarkers.
    Zec H; Shin DJ; Wang TH
    Expert Rev Mol Diagn; 2014 Sep; 14(7):787-801. PubMed ID: 25109704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omics-based nanomedicine: the future of personalized oncology.
    Rosenblum D; Peer D
    Cancer Lett; 2014 Sep; 352(1):126-36. PubMed ID: 23941830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying your body: a how-to guide from a systems biology perspective.
    Smarr L
    Biotechnol J; 2012 Aug; 7(8):980-91. PubMed ID: 22887886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The faces of personalized medicine: a framework for understanding its meaning and scope.
    Redekop WK; Mladsi D
    Value Health; 2013; 16(6 Suppl):S4-9. PubMed ID: 24034312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beginning of personalized medicine in sepsis: small steps to a bright future.
    Christaki E; Giamarellos-Bourboulis EJ
    Clin Genet; 2014 Jul; 86(1):56-61. PubMed ID: 24579691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifetime experiences, the brain and personalized medicine: an integrative perspective.
    McEwen BS; Getz L
    Metabolism; 2013 Jan; 62 Suppl 1():S20-6. PubMed ID: 23009787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine policy challenges: measuring clinical utility at point of care.
    van Rooij T; Wilson DM; Marsh S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):289-95. PubMed ID: 22812553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some imminent but overlooked preanalytical and analytical challenges currently facing biomarkers and companion diagnostics.
    Halim AB
    Ann N Y Acad Sci; 2015 Jun; 1346(1):63-70. PubMed ID: 25758153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
    Villoslada P; Baranzini S
    J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsible healthcare innovation: anticipatory governance of nanodiagnostics for theranostics medicine.
    Fisher E; Boenink M; van der Burg S; Woodbury N
    Expert Rev Mol Diagn; 2012 Nov; 12(8):857-70. PubMed ID: 23249203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preface for companion diagnostics.
    Carini C
    Ann N Y Acad Sci; 2015 Jun; 1346(1):v-vi. PubMed ID: 26099691
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed.
    Várady G; Cserepes J; Németh A; Szabó E; Sarkadi B
    Biomark Med; 2013 Oct; 7(5):803-19. PubMed ID: 24044572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.